Frontiers in Cardiovascular Medicine · Nov 10, 2026
CPET-guided home-based exercise training after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: a pilot randomized controlled trial
By Yan Cheng, Xinxin Wang, Hanbin Luo et al.
Background: Balloon pulmonary angioplasty (BPA) improves pulmonary hemodynamics in chronic thromboembolic pulmonary hypertension (CTEPH), but many patients still experience residual exercise intolerance and psychological distress. The efficacy and safety of home-based exercise specifically for CTEPH patients after BPA remain unclear. Methods: This single-centre, prospective, pilot randomized controlled trial randomized 42 clinically stable CTEPH patients (1:1) 1–3 days after an index BPA to a 12-week exercise programme or usual care. The exercise group received five supervised in-hospital familiarization sessions, followed by home-based brisk walking (30 min/day), Tai Chi (18 min/day), and incentive spirometry during weeks 2–12. Controls maintained usual daily activities. The primary outcome was change in peak oxygen uptake (VO₂peak). Continuous outcomes were analyzed in complete cases using baseline-adjusted ANCOVA, with sensitivity analyses for the primary outcome. Results: Of 42 randomized participants (21 per group), 30 completed the 12-week assessment (15 per group). VO₂peak changed by −0.57 ± 3.14 mL/kg/min in controls and +2.19 ± 2.01 mL/kg/min in the exercise group (baseline-adjusted difference 1.15 mL/kg/min; 95% CI −0.66 to 2.96; P=0.204). 6MWD changes were +21.9 ± 29.5 m and +54.2 ± 48.2 m, respectively (adjusted difference 24.9 m; 95% CI −3.5 to 53.4; P=0.083). At 12 weeks, WHO-FC III was present in 7/15 controls and 0/15 exercise participants; due to complete separation and a pre-existing baseline difference in functional class, this is reported descriptively only. Other continuous secondary outcomes were not statistically significant. No serious exercise-related adverse events were reported. Conclusion: The CPET-guided home-based programme was implementable and safe. Although numerical changes in VO₂peak and 6MWD favored exercise, baseline-adjusted comparisons were imprecise, with wide confidence intervals crossing the null, and were not statistically significant. Unadjusted and baseline-adjusted analyses of the primary outcome gave discordant results, providing no robust evidence of efficacy. These hypothesis-generating findings require confirmation in adequately powered trials.